Announcements Trials

Browse Landscape

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non-Squamous Non-Small Cell Lung Cancer 1 Head and Neck Neoplasms 1

Interventions

Carboplatin 25 Bevacizumab 18 Paclitaxel 17 Pemetrexed 16 Erlotinib Hydrochloride 14 Radiotherapy 12 Docetaxel 9 Gemcitabine 7 Cisplatin 6 ceritinib 5 Taxes 5 Cetuximab 5 pembrolizumab 3 pegfilgrastim 3 capmatinib 3 Surgical Procedures, Operative 3 Radiosurgery 3 Metformin 3 Gefitinib 3 Cyclophosphamide 3 Thalidomide 2 Sorafenib 2 Radiotherapy, Conformal 2 Nivolumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Albumin-Bound Paclitaxel 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma of Lung × Platinum Compounds × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡